INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2004

Pomegranate juice ellagitannins were not absorbed intact in healthy adults but were metabolized by colonic microflora into dibenzopyranone derivatives.

Six healthy adults drank 1 L of pomegranate juice daily for 5 days to assess ellagitannin bioavailability, blood parameters, and antioxidant activity. Neither punicalagin nor ellagic acid were detected in plasma or urine; instead, three colonic microflora-derived metabolites were found, reaching up to 18.6 microM in plasma with urine excretion ranging from 0.7 to 52.7% of ingested punicalagin. No relevant effect was observed on any blood parameter, and the metabolites lacked significant antioxidant activity compared to punicalagin.

Study type
Interventional study
Who was studied
6 healthy subjects (4 men and 2 women)
What was measured
Bioavailability and metabolism of ellagitannins, blood hematological/serobiochemical parameters, and in vitro antioxidant activity

THE PAPER

The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans.

Cerdá B, Espín JC, Parra S, Martínez P, Tomás-Barberán FA. Eur J Nutr, 2004.

PubMed 15309440 ↗DOI 10.1007/s00394-004-0461-7 ↗

Gut & microbiomeNutrients & adequacy

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.